Research and Development

Showing 15 posts of 9573 posts found.

Universal WorldEvents creates dedicated training role

February 14, 2013 Medical Communications, Research and Development, Sales and Marketing Universal WorldEvents

Event management firm Universal WorldEvents has announced the promotion of Sarah Longland to the new role of senior account manager …
currie_mark_ironwood

Ironwood announces new president of R&D

February 13, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Ironwood

Ironwood Pharmaceuticals has announced the promotion of Mark Currie, to senior vice president, chief scientific officer, and president of research …
rajiv_malik

Mylan appoints two heads to Board of directors

February 12, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Mylan

Mylan has announced the appointment of Melina Higgins, a former partner at Goldman Sachs, and Rajiv Malik, currently Mylan’s president, …
FDA image

FDA offers Alzheimer’s guidance

February 11, 2013 Research and Development, Sales and Marketing Alzheimer's, FDA, Roche, lilly

The FDA has issued guidance to help companies developing new treatments for patients with early-stage Alzheimer’s disease. The US regulator’s …
screen_shot_2013-02-11_at_11

Teva appoints Arie Belldegrun to Board of directors

February 11, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Arie Belldegrun, Teva

Teva Pharmaceuticals has announced that Dr Arie Belldegrun has been appointed by the directors of Teva to fill a vacancy …

£20m research boost for Scottish biotech

February 11, 2013 Research and Development, Sales and Marketing Bayer, BioCity Scotland, Dundee, EFPIA

BioCity Scotland and the University of Dundee are to play key roles in a newly-launched pan-European drug discovery project. In …

Contract research news in brief

February 11, 2013 Research and Development Antabio, Aptuit, Argenta, Cross Country Healthcare, ICON, PPD, Quintiles, Verum.de

Icon offers $52m for CCH’s clinical services division, plus updates from PPD, Aptuit, Argenta, Quintiles and Verum.de.
lilly image

Lilly abandons RA drug

February 8, 2013 Research and Development, Sales and Marketing RA, lilly, tabalumab

Lilly is abandoning its late-stage trial into investigational rheumatoid arthritis (RA) drug tabalumab but insists the move has nothing to …
image

Market access: please, no more talk of ‘hurdles’ and ‘obstacles’

February 7, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing barr, market access, pm society

For the UK pharmaceutical industry, biotech or devices firms, any discussion around market access tends to be synonymous with ‘hurdles’ …

Bayer/Janssen seek Xa inhibitor antidote

February 6, 2013 Research and Development, Sales and Marketing Bayer, Janssen, PRT4445, Xarelto

Bayer HealthCare and Janssen Pharmaceuticals have signed a deal with Portola Pharmaceuticals to evaluate the safety of an investigational antidote …
GSK image

GSK announces AllTrials support

February 6, 2013 Research and Development, Sales and Marketing ABPI, Bad pharma, GSK, Goldacre

GlaxoSmithKline has this morning found itself in the unusual position of being showered with praise by one of its fiercest …
screen_shot_2013-02-05_at_14

Aesica recruits operations director

February 5, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Aesica, CMO

Contract manufacturing organisation (CMO) Aesica has appointed Jarrett Palmer as Operations director of its formulated products business unit business. Palmer …
lennernas_2

Recipharm appoints Hans Lennernäs to operating Board

February 5, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Recipharm

Recipharm Pharmaceutical Development AB has announced the appointment of Dr Hans Lennernäs to the company’s Board of directors. Lennernäs is …
lilly image

Survey shock for pharma

February 4, 2013 Medical Communications, Research and Development, Sales and Marketing Cancer, PACE, lilly, pharma, research

A survey released to tie in with today’s World Cancer Day finds that most people feel pharma companies see cancers …
dalton

NHS Commissioning Board executive departs

February 4, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CB, Dalton, NHS

The NHS Commissioning Board has announced the forthcoming departure of its chief operating officer and deputy chief executive. Ian Dalton …
The Gateway to Local Adoption Series

Latest content